NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









OM1

OM1

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.om1.com/

Last Round

Series D

Jul 16, 2021

Total Funding Raised

$171M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

OM1 is a healthcare technology company that provides an AI-powered platform for measuring, comparing, and predicting treatment outcomes using real-world clinical data.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Clinical Trials, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting, Subscription SaaS

AI Layer

Foundation

Keywords

real-world evidenceRWEhealthcare foundation modelclinical data registrypredictive modelingregulatory submissionpatient findingdigital phenotypingclinical trial accelerationmedical AIhealth data cloudhealthtechdata as a serviceDaaSEHR integration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OM1 Comparables

Compare OM1 with similar companies based on industry and business-model similarity.

OM1 comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HealthVerity
87%
Verana Health
87%
TriNetX
87%

OM1 Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJul 16, 2021
Series CDec 18, 2019
Series BMay 22, 2018
Series AApr 6, 2017

Key People

Founding team and executive leadership

Rich Gliklich

CEO

Executive Team

Dennis Reilly

Chief Financial Officer

Executive Team

Hunter Lane

Chief Product Officer

Executive Team

OM1 Investors

Notable investors and investment history

OM1 investors
InvestorRounds
Breyer CapitalSeries D
7wire VenturesSeries C, Series A, Series D, Series B
Scale Venture PartnersSeries D, Series C
General CatalystSeries C, Series A, Series D, Series B
D1 Capital PartnersSeries D
Polaris PartnersSeries C, Series D, Series B
Wanxiang Healthcare InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 8, 2026

    Added ZS, a healthcare consulting firm, as a customer.

  • Feb 8, 2026

    Added Ppd Development, Inc. in Pharmaceuticals/Clinical Research as a customer.

OM1 Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OM1 Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OM1's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range100
Year Founded2015
Last FundingJul 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.